News | July 28, 2023
Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
Dr. Lal Path Labs Ltd. has reported total income of Rs. 555.4 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023
Marks the World Head & Neck Cancer Day at the OCTF Conference
Uses a simple mechanical approach for removing intrauterine tissues
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Jubilant Ingrevia has reported total income of Rs. 1083.52 crores during the period ended June 30, 2023
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Subscribe To Our Newsletter & Stay Updated
